Skip to main content
Rutgers logo

Enter a Search Term

Rutgers logo
  • Visit Rutgers.edu
  • Find Experts
  • Get Research Help
    • News
    • Events
    • Award Announcements
  • Giving
Rutgers logo
  • For Faculty & Staff
    • Find Funding
    • Pre-Award
      • Proposal Development & Submissions
      • Budget Preparation
      • Sponsored Programs & Subawards
    • Post-Award
      • Grant Management
      • Financial Compliance
      • Non-Financial Services
    • Compliance
      • Human Research Protection
      • Institutional Animal Care and Use Committee
      • Report Research Misconduct
    • Core Services
      • Find a Core Facility
      • Become a Core Facility
      • Information for Existing Core Facilities
      • Animal Care
    • Inventions & Commercialization
      • Submit and Protect Your Invention
      • License & Commercialize
      • Startup Support
      • Agriculture
      • Rutgers Innovation Awards
    • Contract Support
    • Federal Government FAQs
  • For Industry & Government
    • Connect With Us
    • Available Technologies
    • Rutgers Startups
    • Core Services & Facilities
    • Areas of Research
  • Tools & Resources
    • Resource Library
    • Research Administration Handbook
    • Systems & Applications
    • Research Dashboard Portal
    • Networks & Committees
    • Workshops & Training
  • About
    • Office for Research (OfR)
    • Research By The Numbers
      • Higher Education Research and Development (HERD) Survey
    • Internships & Career Opportunities
    • Get Research Help
    • Staff Directory
Rutgers logo
  • For Faculty & Staff
    • Find Funding
    • Pre-Award
      • Proposal Development & Submissions
      • Budget Preparation
      • Sponsored Programs & Subawards
    • Post-Award
      • Grant Management
      • Financial Compliance
      • Non-Financial Services
    • Compliance
      • Human Research Protection
      • Institutional Animal Care and Use Committee
      • Report Research Misconduct
    • Core Services
      • Find a Core Facility
      • Become a Core Facility
      • Information for Existing Core Facilities
      • Animal Care
    • Inventions & Commercialization
      • Submit and Protect Your Invention
      • License & Commercialize
      • Startup Support
      • Agriculture
      • Rutgers Innovation Awards
    • Contract Support
    • Federal Government FAQs
  • For Industry & Government
    • Connect With Us
    • Available Technologies
    • Rutgers Startups
    • Core Services & Facilities
    • Areas of Research
  • Tools & Resources
    • Resource Library
    • Research Administration Handbook
    • Systems & Applications
    • Research Dashboard Portal
    • Networks & Committees
    • Workshops & Training
  • About
    • Office for Research (OfR)
    • Research By The Numbers
      • Higher Education Research and Development (HERD) Survey
    • Internships & Career Opportunities
    • Get Research Help
    • Staff Directory
  • Visit Rutgers.edu
  • Find Experts
  • Get Research Help
    • News
    • Events
    • Award Announcements
  • Giving
  • For Faculty & Staff
  • Internal Research Funding Opportunities
  • HealthAdvance
  • Funded Projects

Stethoscope on desk with pen and graphs

HealthAdvance Funded Projects

Explore the latest projects funded through our funding platform that aims to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics and tools to improve health and patient care. 

COVID19 illustration  - breathalizer
COVID-19

Rutgers Researchers Receive Award to Develop Rapid Sensor to Detect COVID-19 and Other Infectious Diseases within a Person’s Breath

A team of Rutgers researchers merged their ideas and technology with the support of research mentors to get the needed funds for developing a novel device capable of detecting the presence of viruses like SARS-CoV-2 in one’s breath.

  • HealthAdvance Fund®
Graphic for Huizhou Fan HealthAdvance Project ChlamVax Advantage
HealthAdvance Fund®

Development of Maturation-defective Attenuated Chlamydia Vaccines

Chlamydiae are common and important human pathogens. This HealthAdvance grant will apply a novel technology to develop a safe and effective life attenuated Chlamydia vaccine. Our vaccines will drastically reduce health and socioeconomic burdens of chlamydial diseases in women and men.

gsx1-gene-therapy-for-spinal-cord-injury
HealthAdvance Fund®

Gsx1 Gene Therapy for Spinal Cord Injury

We have developed a novel, first-in-class GSX1 gene therapy that promotes the regeneration of spinal cord tissue, resulting in dramatic functional recovery in an animal model of spinal cord injury (SCI).

antibacterialdrugleaddevelopment_eftu-trna_figure_emanuel_goldman
HealthAdvance Fund®

Antibacterial Drug Lead Development

Many bacterial diseases are becoming more deadly as bacteria develop resistance to treatment with antibiotics. The proposed work describes an innovative path to identifying novel antibiotics.

quantum-click-next-gen-virtual-screening-for-drug-discovery
HealthAdvance Fund®

Quantum Click: Next-gen Virtual Screening for Drug Discovery

Quantum Click is a software capable of formulating new drug candidates by screening billions of compounds virtually. Due to the exceptionally high accuracy, Quantum Click provides robust predictions of drug candidate-protein target interactions.

Visual description of A Novel Method of Generating Live-Attenuated, Replication-Defective DNA Viruses for Vaccine Development
HealthAdvance Fund®

A Novel Method of Generating Live-Attenuated, Replication-Defective DNA Viruses for Vaccine Development

The long-term goal of this project is to develop a vaccine using centanamycin for DNA viruses where no drug or vaccine is available. Our study offers an attractive opportunity to develop chemically-attenuated live viruses as vaccines for the prevention and treatment of DNA viral infections.

Visual description of Magnetic Nanoparticle-Assisted Non-Viral CRISPR-Cas9 for Advanced Genome Editing
HealthAdvance Fund®

Magnetic Nanoparticle-Assisted Non-Viral CRISPR-Cas9 for Advanced Genome Editing

One of the most critical hurdles to developing CRISPR-based therapies for genetic disorders is the lack of effective delivery systems. To this end, this project aims todevelop a next-generation CRISPR delivery solution for fast and effective genome editing that supports the need for the CRISPR-based drug development market.

Visual description of Nervana technology
HealthAdvance Fund®

Cellularized Nerve Remediation Graft (CNRG)

The proposed technology will repair peripheral nerve injuries (PNI) by utilizing a biodegradable biopolymer scaffold enclosing a hydrogel-peptide matrix-based 3Dsystem combined with cultured autologous human cells to augment nerve growth once implanted.

high-affinity-bispecific-killer-cell-engager-for-cancer-immunotherapy_arash_hatefi
HealthAdvance Fund®

High Affinity Bispecific Killer Cell Engager for Cancer Immunotherapy

We have engineered a bispecific killer cell engager (BiKE) that binds to CD16a receptors on the surface of natural killer (NK) cells with high affinity and specificity.

KasA
HealthAdvance Fund®

A New Tuberculosis Drug Targeting KasA

Tuberculosis is characterized by 10 million cases and 1.5 million deaths per year. New drugs are needed to reduce treatment duration and to treat drug-resistant infections. We propose a solution based on our preclinical drug lead (JSF-3285) that inhibits the essential ß-ketoacyl synthase and exhibits promising efficacy and safety profiles. 

  • Load More

Site Footer

  • New Brunswick
  • Newark
  • Camden
  • Rutgers Health

CONNECT

  • Contact Research Staff
  • Research With Rutgers
  • Subscribe to our Newsletter
  • Give to Rutgers
  • Work at Rutgers
  • myRutgers
  • Visit Rutgers.edu

ABOUT US

QUICK ACCESS TO RESEARCH SYSTEMS

  • RAPSS
  • eIRB
  • eCRT
  • eCOI
  • IPAS
  • eIACUC
  • ACFC
  • ARC
  • MyREHS

HOW TO REPORT

  • Research Misconduct
  • Animal Welfare Concerns
  • Accessibility Barrier
  • Website Feedback

Follow Us

Rutgers is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers websites to accessibility@rutgers.edu or complete the Report Accessibility Barrier / Provide Feedback form.

Copyright ©2025, Rutgers, The State University of New Jersey. All rights reserved.